Xtacy Therapeutics Corp. (TSE:XTCY) has released an update.
Xtacy Therapeutics Corp. has completed the filing of its annual financial statements for the fiscal year ending September 30, 2023, and related management discussions and certifications, now available on SEDAR+ and the CSE website. The company is working to resolve a voluntary management cease trade order by fulfilling its obligations for the upcoming Q1 Interim Financial statements. Xtacy Therapeutics, a company aiding high growth firms in wellness consumer products, reassures that there have been no significant business changes apart from the recent financial disclosures.
For further insights into TSE:XTCY stock, check out TipRanks’ Stock Analysis page.
